The U.S. Food and Drug Administration has given 510k approval to Filligent for its BioFriend BioMask (series A) anti-viral surgical facemask, according to a company news release.
Read the full report in Becker’s Hospital Review on Filligent’s BioFriend BioMask.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
